mitomycin has been researched along with Cancer of the Urinary Tract in 20 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Patient demographics, the timing of MMC instillation, adverse events (surgical and potentially MMC-related) and length of stay (LOS) were assessed according to the Clavien-Dindo classification." | 1.56 | Safety and feasibility of early single-dose mitomycin C bladder instillation after robot-assisted radical nephroureterectomy. ( Barod, R; Bex, A; Cullen, D; Gulamhusein, A; Mumtaz, F; Patki, P; Silva, P; Tran, M, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (25.00) | 18.7374 |
| 1990's | 3 (15.00) | 18.2507 |
| 2000's | 4 (20.00) | 29.6817 |
| 2010's | 5 (25.00) | 24.3611 |
| 2020's | 3 (15.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dreicer, R | 1 |
| Gulamhusein, A | 1 |
| Silva, P | 1 |
| Cullen, D | 1 |
| Tran, M | 1 |
| Mumtaz, F | 1 |
| Patki, P | 1 |
| Barod, R | 1 |
| Bex, A | 1 |
| Porta, C | 1 |
| Giannatempo, P | 1 |
| Rizzo, M | 1 |
| Lucarelli, G | 1 |
| Ditonno, P | 1 |
| Battaglia, M | 1 |
| Somani, BK | 1 |
| Chen, SK | 1 |
| Chung, CA | 1 |
| Cheng, YC | 1 |
| Huang, CJ | 1 |
| Ruaan, RC | 1 |
| Chen, WY | 1 |
| Li, C | 1 |
| Tsao, CW | 1 |
| Hu, WW | 1 |
| Chien, CC | 1 |
| Seisen, T | 1 |
| Colin, P | 1 |
| Rouprêt, M | 1 |
| Bhattacharyya, M | 1 |
| Powles, T | 1 |
| Mutsvangwa, K | 1 |
| Wilson, P | 1 |
| Oliver, T | 1 |
| Shamash, J | 1 |
| Cutress, ML | 1 |
| Stewart, GD | 1 |
| Zakikhani, P | 1 |
| Phipps, S | 1 |
| Thomas, BG | 1 |
| Tolley, DA | 1 |
| Palou, J | 1 |
| Piovesan, LF | 1 |
| Huguet, J | 1 |
| Salvador, J | 1 |
| Vicente, J | 1 |
| Villavicencio, H | 1 |
| Di Stasi, SM | 1 |
| Giannantoni, A | 1 |
| Stephen, RL | 1 |
| Storti, L | 1 |
| Attisani, F | 1 |
| Sansalone, S | 1 |
| Virgili, G | 1 |
| Fujihiro, S | 1 |
| Takeuchi, T | 1 |
| Fujimoto, Y | 1 |
| Okano, M | 1 |
| Horie, M | 1 |
| Kanematsu, M | 1 |
| Kuriyama, M | 1 |
| Ban, Y | 1 |
| Nishiura, T | 1 |
| Tannock, IF | 1 |
| Gaboardi, F | 1 |
| Bozzola, A | 1 |
| Dotti, E | 1 |
| Galli, L | 1 |
| Hayes, MC | 1 |
| Birch, BR | 1 |
| Cooper, AJ | 1 |
| Primrose, JN | 1 |
| Mitsumori, K | 1 |
| Sato, K | 1 |
| Kato, T | 1 |
| Sahashi, M | 2 |
| Ono, Y | 2 |
| Matsuura, O | 1 |
| Ohshima, S | 2 |
| Fukushima, M | 1 |
| Gelabert Mas, A | 1 |
| Arango, O | 1 |
| Rosales, A | 1 |
| Coronado, J | 1 |
| Moreno, A | 1 |
| Fujita, T | 1 |
| Aso, Y | 1 |
| Aota, Y | 1 |
| Murase, T | 1 |
| Takashi, M | 1 |
| Ito, H | 1 |
| Shimoji, T | 1 |
| Miyake, K | 1 |
| Mitsuya, H | 1 |
| Tari, K | 1 |
| Satake, I | 1 |
| Kojima, S | 1 |
| Negishi, T | 1 |
| Yoshida, K | 1 |
| Nakame, Y | 1 |
| Kanaoya, F | 1 |
| Horiuchi, S | 1 |
| Saito, T | 1 |
| Owada, F | 1 |
4 reviews available for mitomycin and Cancer of the Urinary Tract
| Article | Year |
|---|---|
An evaluation of UGN-101, a sustained-release hydrogel polymer-based formulation containing mitomycin-C, for the treatment of upper urothelial carcinomas.
Topics: Antibiotics, Antineoplastic; Carcinoma, Transitional Cell; Clinical Trials as Topic; Delayed-Action | 2020 |
Risk-adapted strategy for the kidney-sparing management of upper tract tumours.
Topics: Administration, Intravesical; Algorithms; Antibiotics, Antineoplastic; Carcinoma, Transitional Cell; | 2015 |
Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review.
Topics: Antibiotics, Antineoplastic; BCG Vaccine; Biopsy; Carcinoma, Transitional Cell; Chemotherapy, Adjuva | 2012 |
[Intra-arterial chemotherapy in urological cancer].
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capsules; Carcinoma, Re | 2002 |
3 trials available for mitomycin and Cancer of the Urinary Tract
| Article | Year |
|---|---|
A phase II study of mitomycin, fluorouracil, folinic acid, and irinotecan (MFI) for the treatment of transitional cell carcinoma of the bladder.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Camptothecin; Carcinoma, Transitional | 2013 |
Combination chemotherapy for advanced urothelial-tract carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin | 1992 |
Three-drug combination chemotherapy for advanced urothelial tract carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Transitional Cell | 1987 |
13 other studies available for mitomycin and Cancer of the Urinary Tract
| Article | Year |
|---|---|
New mitomycin formulation for low-grade upper tract urothelial cancer.
Topics: Carcinoma, Transitional Cell; Humans; Mitomycin; Urologic Neoplasms; Urothelium | 2020 |
Safety and feasibility of early single-dose mitomycin C bladder instillation after robot-assisted radical nephroureterectomy.
Topics: Administration, Intravesical; Aged; Antibiotics, Antineoplastic; Female; Humans; Male; Middle Aged; | 2020 |
Editorial Comment on: Induction and Maintenance Adjuvant Mitomycin C Topical Therapy for Upper Tract Urothelial Carcinoma: Tolerability and Intermediate Term Outcomes by Metcalfe et al.
Topics: Adjuvants, Immunologic; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Humans; Kidney Neoplas | 2017 |
Hydrostatic pressure enhances mitomycin C induced apoptosis in urothelial carcinoma cells.
Topics: Antibiotics, Antineoplastic; Apoptosis; Bioreactors; Caspase 3; Caspase 7; Cell Line, Tumor; Cell Pr | 2014 |
Percutaneous nephroscopic management of upper urinary tract transitional cell carcinoma: recurrence and long-term followup.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Endo | 2004 |
Percutaneous sequential bacillus Calmette-Guèrin and mitomycin C for panurothelial carcinomatosis.
Topics: Adjuvants, Immunologic; Antibiotics, Antineoplastic; BCG Vaccine; Carcinoma; Drug Therapy, Combinati | 2005 |
[Chemotherapy of urothelial cancer with vincristine, mitomycin C, bleomycin, tegafur and OK-432].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Female; | 1984 |
Methotrexate and mitomycin for patients with metastatic transitional cell carcinoma of the urinary tract.
Topics: Antineoplastic Agents; Carcinoma, Transitional Cell; Drug Evaluation; Drug Therapy, Combination; Hum | 1983 |
Conservative treatment of upper urinary tract tumors with Nd:YAG laser.
Topics: Adult; Combined Modality Therapy; Endoscopy; Hematuria; Humans; Laser Therapy; Male; Mitomycin; Neop | 1994 |
Cellular resistance to mitomycin C is associated with overexpression of MDR-1 in a urothelial cancer cell line (MGH-U1).
Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Drug Resistanc | 2001 |
Eosinophilic cystitis and allergy to mitomycin-C.
Topics: Aged; Antineoplastic Agents; Carcinoma, Transitional Cell; Cystitis; Eosinophilia; Female; Humans; M | 1990 |
[A study of postoperative adjuvant chemotherapy of advanced urinary epithelial cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Transitional Cell; Cispl | 1988 |
[Prophylactic intravesical chemotherapy in bladder tumors after surgery of upper tract urothelial carcinoma].
Topics: Administration, Intravesical; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carbazilq | 1987 |